triphosphoric acid has been researched along with 2019 Novel Coronavirus Disease in 8 studies
triphosphoric acid: used as water softener, peptizing agent, emulsifier & dispersing agent; ingredient of cleansers; meat preservative; RN given refers to parent cpd; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Molnupiravir is an antiviral that has shown clinical efficacy against mild-to-moderate COVID-19 but failed to provide benefit to hospitalized patients with severe disease." | 1.72 | Why Molnupiravir Fails in Hospitalized Patients. ( Brown, AN; Bulitta, JB; Drusano, GL; Franco, EJ; Hanrahan, KC; Lang, Y; Zhou, J, 2022) |
| "Favipiravir has discrepant activity against SARS-CoV-2 in vitro, concerns about teratogenicity and pill burden, and an unknown optimal dose." | 1.62 | Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5'-triphosphate exposure to support posology for SARS-CoV-2. ( Khoo, SH; Owen, A; Pertinez, H; Rajoli, RKR, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillis, TD | 1 |
| Bearne, SL | 1 |
| Song, Z | 2 |
| Wang, Q | 1 |
| Bian, L | 1 |
| An, C | 2 |
| Cui, B | 2 |
| Mao, Q | 2 |
| Wu, X | 1 |
| He, Q | 2 |
| Bai, Y | 2 |
| Liu, J | 3 |
| Song, L | 1 |
| Liu, D | 2 |
| Zhang, J | 2 |
| Gao, F | 1 |
| Li, X | 1 |
| Liang, Z | 2 |
| Brown, AN | 1 |
| Lang, Y | 1 |
| Zhou, J | 1 |
| Franco, EJ | 1 |
| Hanrahan, KC | 1 |
| Bulitta, JB | 1 |
| Drusano, GL | 1 |
| Gioia, U | 1 |
| Tavella, S | 1 |
| MartÃnez-Orellana, P | 1 |
| Cicio, G | 1 |
| Colliva, A | 1 |
| Ceccon, M | 1 |
| Cabrini, M | 1 |
| Henriques, AC | 1 |
| Fumagalli, V | 1 |
| Paldino, A | 1 |
| Presot, E | 1 |
| Rajasekharan, S | 1 |
| Iacomino, N | 1 |
| Pisati, F | 1 |
| Matti, V | 1 |
| Sepe, S | 1 |
| Conte, MI | 1 |
| Barozzi, S | 1 |
| Lavagnino, Z | 1 |
| Carletti, T | 1 |
| Volpe, MC | 1 |
| Cavalcante, P | 1 |
| Iannacone, M | 1 |
| Rampazzo, C | 1 |
| Bussani, R | 1 |
| Tripodo, C | 1 |
| Zacchigna, S | 1 |
| Marcello, A | 1 |
| d'Adda di Fagagna, F | 1 |
| Zhang, X | 1 |
| Li, K | 1 |
| Cheng, F | 1 |
| Chen, KL | 1 |
| Wang, FS | 1 |
| Hu, WJ | 1 |
| Chang, L | 1 |
| Yang, Y | 1 |
| Wang, X | 1 |
| Xie, YC | 1 |
| Shen, JS | 1 |
| Tan, B | 1 |
| Pertinez, H | 1 |
| Rajoli, RKR | 1 |
| Khoo, SH | 1 |
| Owen, A | 1 |
8 other studies available for triphosphoric acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Effects of the 5'-Triphosphate Metabolites of Ribavirin, Sofosbuvir, Vidarabine, and Molnupiravir on CTP Synthase Catalysis and Filament Formation: Implications for Repurposing Antiviral Agents against SARS-CoV-2.
Topics: Antiviral Agents; COVID-19; Cytidine; Escherichia coli; Humans; Ribavirin; SARS-CoV-2; Sofosbuvir; V | 2022 |
A Short 5'triphosphate RNA nCoV-L Induces a Broad-Spectrum Antiviral Response by Activating RIG-I.
Topics: Animals; Antiviral Agents; Cell Line; COVID-19; DEAD Box Protein 58; DEAD-box RNA Helicases; Humans; | 2022 |
Why Molnupiravir Fails in Hospitalized Patients.
Topics: Antiviral Agents; COVID-19; Humans; SARS-CoV-2 | 2022 |
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence.
Topics: Animals; Cellular Senescence; COVID-19; DNA Damage; Mice; SARS-CoV-2 | 2023 |
A Novel Targeted RIG-I Receptor 5'Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine.
Topics: ABO Blood-Group System; Adjuvants, Immunologic; Adjuvants, Vaccine; Animals; Antibodies, Neutralizin | 2023 |
Cell-specific genome-scale metabolic modeling of SARS-CoV-2-infected lung to identify antiviral enzymes.
Topics: Antiviral Agents; COVID-19; Dihydroorotate Dehydrogenase; Humans; Lipids; Lung; SARS-CoV-2 | 2023 |
Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Kidn | 2021 |
Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5'-triphosphate exposure to support posology for SARS-CoV-2.
Topics: Amides; Animals; Antiviral Agents; COVID-19; Dogs; Humans; Polyphosphates; Pyrazines; SARS-CoV-2 | 2021 |